These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22315437)

  • 1. Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease.
    Friso S; Lotto V; Choi SW; Girelli D; Pinotti M; Guarini P; Udali S; Pattini P; Pizzolo F; Martinelli N; Corrocher R; Bernardi F; Olivieri O
    J Med Genet; 2012 Mar; 49(3):192-9. PubMed ID: 22315437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis.
    Bozzini C; Girelli D; Bernardi F; Ferraresi P; Olivieri O; Pinotti M; Martinelli N; Manzato F; Friso S; Villa G; Pizzolo F; Beltrame F; Corrocher R
    Thromb Haemost; 2004 Sep; 92(3):541-9. PubMed ID: 15351850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease].
    Kang W; Wang H; Xiong L; Wang X; Chu H; Qu B; Liu X; Yin J; Duan B; Yu J; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):457-9. PubMed ID: 12482354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
    Lindman AS; Pedersen JI; Arnesen H; Hjerkinn EM; Veierød MB; Prydz H; Seljeflot I
    Thromb Res; 2004; 113(1):57-65. PubMed ID: 15081566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
    Vogiatzi K; Voudris V; Apostolakis S; Kochiadakis GE; Thomopoulou S; Zaravinos A; Spandidos DA
    Thromb Res; 2009 May; 124(1):84-9. PubMed ID: 19201454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.
    Sabater-Lleal M; Martínez-Marchán E; Martínez-Sánchez E; Coll M; Vallvé C; Mateo J; Souto JC; Fontcuberta J; Soria JM
    Haematologica; 2003 Aug; 88(8):906-13. PubMed ID: 12935978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variations within the genes related to hemostatic imbalance and their impact on coronary artery disease in Turkish population.
    Taymaz H; Erarslan S; Oner ET; Alkan T; Ağirbaşli M; Kirdar B
    Thromb Res; 2007; 119(1):55-62. PubMed ID: 16472842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients.
    Giacconi R; Cipriano C; Muti E; Costarelli L; Malavolta M; Caruso C; Lio D; Mocchegiani E
    Biogerontology; 2006; 7(5-6):347-56. PubMed ID: 16953332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the (TAAAA)n alleles at the SHBG gene promoter for the severity of coronary artery disease in postmenopausal women.
    Alevizaki M; Saltiki K; Xita N; Cimponeriu A; Stamatelopoulos K; Mantzou E; Doukas C; Georgiou I
    Menopause; 2008; 15(3):461-8. PubMed ID: 18188141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma activated coagulation factor VII and Msp I polymorphism in elderly patients with coronary heart disease].
    Lu QH; Du YM; Dong ZQ; Lu FH; Wen PE; Wang KZ; Tian Q; Sun H; Shang Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):691-3. PubMed ID: 16331575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant.
    Humphries S; Temple A; Lane A; Green F; Cooper J; Miller G
    Thromb Haemost; 1996 Apr; 75(4):567-72. PubMed ID: 8743180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.
    Su ZG; Zhang SZ; Hou YP; Zhang L; Huang DJ; Liao LC; Xiao CY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):780-5. PubMed ID: 12417924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease.
    Shanker J; Perumal G; Maitra A; Rao VS; Natesha BK; John S; Hebbagodi S; Kakkar VV
    J Genet; 2009 Dec; 88(3):291-7. PubMed ID: 20086294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
    Wainstein RV; Wainstein MV; Ribeiro JP; Dornelles LV; Tozzati P; Ashton-Prolla P; Ewald IP; Vietta G; Polanczyk CA
    Clin Biochem; 2010 Jan; 43(1-2):57-62. PubMed ID: 19651119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphic markers Ala455Val of the THBD gene and Arg353Gln of the F7 gene and association with unfavorable outcomes of coronary atherosclerosis in patients with a history of acute ischemic heart disease].
    Pushkov AA; Blagodatskikh KA; Nikitin AG; Agapkina IuV; Brovkin AN; Chudakova DA; Evdokimova MA; Aseĭcheva OIu; Osmolovskaia VS; Minushkina LO; Baklanova TN; Talyzin PA; Donetskaia OP; Tereshchenko SN; Dzhaiani NA; Akatova EA; Glezer MG; Galiavich AS; Zakirova VB; Koziolova NA; Iagoda AV; Boeva OI; Horolets EV; Shlyk SV; Volkova EG; Margarian MP; Guz' IO; Konstantinov VO; Sidorenko BA; Zateĭshchikov DA; Nosikov VV
    Genetika; 2011 Oct; 47(10):1386-92. PubMed ID: 22232927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population.
    Yan JJ; Tang NP; Tang JJ; Jia EZ; Wang MW; Wang QM; Zhu J; Yang ZJ; Wang LS; Huang J
    Clin Chim Acta; 2010 Jan; 411(1-2):26-30. PubMed ID: 19804767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
    Ekström M; Silveira A; Bennermo M; Eriksson P; Tornvall P
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):473-7. PubMed ID: 17581323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
    Okura Y; Hayashi K; Shingu T; Kuga Y; Nomura S; Kajiyama G; Nakashima Y; Saku K
    Coron Artery Dis; 2003 Jun; 14(4):285-91. PubMed ID: 12826927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.